Humacyte

VEITHsymposium is packed with so many educational options. Make sure Humacyte is on your list today and stop by booth 312. We are looking forward to seeing you soon. #VEITH2024 #ExhibitBooth312 #LearningTogether #Biotech #Humacyte Poretta & Orr, Exhibits | Events

VEITHsymposium is finally here! Stop by booth # 312 close to the elevators. We are looking forward to seeing you soon. #VEITH2024 #ExhibitBooth312 #LearningTogether #Biotech #Humacyte

Last Tuesday, ISPE had the honor of hosting a company dinner with Humacyte and had the incredible opportunity to learn more about how Humacyte brings innovative technology to the market using human cell lines. We want to extend a heartfelt thank you to the team at Humacyte for joining us at our company dinner. Your presence and the engaging conversations made the evening truly special.? This week, we're looking forward to learning more about the innovation and inner workings of a CDMO! Join us tomorrow as we learn more about FUJIFILM Diosynth Biotechnologies!

Hello New York! We are looking forward to the VEITHsymposium next week! Come visit us at?Exhibit Booth #312?from?Tuesday, November 19th to Friday, November 22nd. We can’t wait to connect and learn together. See you there! #VEITH2024 #ExhibitBooth312 #LearningTogether #Biotech #Humacyte

At Humacyte we honor all those incredible service members who have protected our nation and continue to serve. Thank you for your bravery and sacrifices for all of us. #veteransday #humacyte #biotech #veteran

Humacyte released third quarter financial results with a business update, highlighting progress in our bioengineered human tissue projects. Key updates include: - Ongoing FDA review of the ATEV? for vascular trauma. - Phase 3 trial results for ATEV in hemodialysis patients presented at Kidney Week 2024. - Long-term data of ATEV in treating vascular injuries from the Ukraine conflict, presented at MHSRS, a major U.S. Department of Defense meeting. - Application for an NTAP reimbursement to CMS was submitted in October For more details, read the full press release here: https://lnkd.in/esriRwPG The BioVascular Pancreas and the Acellular Tissue Engineered Vessel (ATEV) are investigational and have not been approved by the FDA or any regulatory agency. #Biotech #Humacyte #EarningsCall #Innovation #investors

Humacyte hosted a Virtual Webinar on October 31st. We were pleased to hear from Dr. Charles Keith Ozaki, Dr. Timmy Lee, and Dr. Mohamad Anas Hussain, who shared case studies for Humacyte’s investigational Acellular Tissue Engineered Vessel ATEV? in addition to clinical trial outcomes from high-need clinical subgroups. A special thanks to our presenters for walking us through your cases and thank you to the attendees for your engagement through the event. Find out more here:?https://lnkd.in/eKfUCcbz #MedicalInnovation #Hemodialysis #AVAccess #Humacyte #Biotech #renaldisease #kidneydisease

Just over a month and a half ago on September 20th, Engineering World Health @ UNC hosted its very first Engineer-A-Thon. Spanning 12 hours, we hosted Dr. Robert Langer, most cited engineer in history and co-founder of Moderna, and Eric Green, M.D., Ph.D., key figure in the Human Genome Project and Director of the National Human Genome Research Institute (NHGRI) over Zoom for some wonderful talks focusing on biomedical engineering, global health, and the future of genomics. Additionally, we focused on instructing students on engineering basics in conjunction with Carolina Adapts Toys for Children, Karthik Ramakrishnan, Daniel Menichella, Seeva Cherukuri, and the other wonderful exec from UNC Biomedical Devices, and Adam Castiller for instructing during the EWH VR Crash Course. We also hosted a design competition surrounding rural health in North Carolina and received excellent submissions from EWH's dedicated members. We would like to extend a special thanks to our incredibly generous sponsors for making this event possible, BIOMOJO and Humacyte. We couldn't have made this event possible without your support! I would also like to thank the wonderful EWH exec team, Dhruv Ranganath, Sriya Dhanikonda, Samanyu Dixit, and Akshay Elango for working on this event tirelessly with me over the summer and through the school year, adapting to all the setbacks and all the issues we faced, and making the event happen no matter what. Finally, we would like to thank Engineering World Health for helping us with our stock and merch, Mike Wilkins, Imran Rizvi, Devin Hubbard, and the Joint Department of Biomedical Engineering | UNC & NC State for all the advice and logistical assistance leading up to the event. We can't wait to see how we proceed with the event in the future, and once again, we extend heartfelt thanks to everyone involved, and most importantly, all of our participants for making this event possible.

Humacyte’s late-breaking abstract on the V007 Phase 3 clinical trial was accepted for an oral presentation at the American Society of Nephrology’s Kidney Week 2024. Dr. Mohamad Anas Hussain, MD, PhD, RPVI, FAHA, FRCSC, FACS was in San Diego on October 26th to present clinical data on the investigational acellular tissue engineered vessel (ATEV?) for arteriovenous access in patients with end-stage renal disease. Read the full press release here: https://lnkd.in/gg7qKTwW #Humacyte #KidneyWeek2024 #ASN #Nephrology #ClinicalTrials #Biotech

Next stop on the #NCMFGTour: Humacyte! This Durham-based biotechnology company is revolutionizing health care with their innovative Human Acellular Vessel. Humacyte's dedication to research and development not only drives medical advancements but also strengthens North Carolina’s #manufacturing sector. Learn more > https://bit.ly/4h3HzGl